BIODESIX, INC. Impairment of Long-Lived Assets Held-for-use
BIODESIX, INC. (BDSX) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-26
- BIODESIX, INC. impairment of long-lived assets held-for-use for the quarter ending 2020-12-31 was $0.00.
- BIODESIX, INC. impairment of long-lived assets held-for-use for the quarter ending 2019-12-31 was $0.00.
- BIODESIX, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- BIODESIX, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- BIODESIX, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- BIODESIX, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-06 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 10-K · filed 2022-03-14 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-12-10 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |